Tristel ( (GB:TSTL) ) has provided an update.
Tristel PLC reported strong interim results for the six months ending December 2024, with an 8% revenue increase to £22.6 million and a 19% rise in adjusted profit before tax to £4.9 million. The company remains debt-free and cash-generative, maintaining a progressive dividend policy. Tristel’s expansion efforts are centered on geographic growth, particularly in the USA, where they anticipate significant opportunities. Key operational highlights include the successful transition of the CEO and a strategic FDA filing for a new disinfectant product, indicating promising growth prospects and industry positioning.
More about Tristel
Tristel PLC operates in the infection prevention industry, focusing on the production of decontamination products for medical devices and environmental surfaces. The company leverages its proprietary chlorine dioxide technology under the Tristel and Cache brands, with a market focus on hospitals and international expansion.
YTD Price Performance: -18.35%
Average Trading Volume: 55,041
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £165.5M
Learn more about TSTL stock on TipRanks’ Stock Analysis page.